hyperimmune intravenous immunoglobulin

Biologicalexperimental

Clinical trial activity

1 trials · 5 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Jan 1, 2010 (NCT01617317)

Timeline

No events for the selected filters.

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • hyperimmune intravenous immunoglobulin

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01617317N/AJan 1, 2010Caritas Medical Centre, Chinese University of Hong Kong, HK Red Cross Blood Transfusion Service, Hong Kong, Research Fund for the Control of Infectious Diseases, Hong Kong, The University of Hong Kong
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (5)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Caritas Medical CentreAcademic/Hospital1012010
Chinese University of Hong KongAcademic/Hospital1012010
HK Red Cross Blood Transfusion Service, Hong KongAcademic/Hospital1012010
Research Fund for the Control of Infectious Diseases, Hong KongAcademic/Hospital1012010
The University of Hong KongAcademic/Hospital1112010
5 organizations
Page 1 / 1